期刊文献+

Pharmacokinetic Study of Baicalein and Its Major Metabolites after iv Administration in Dogs 被引量:5

Pharmacokinetic Study of Baicalein and Its Major Metabolites after iv Administration in Dogs
原文传递
导出
摘要 Objective To develop and validate a simple,rapid,sensitive,and reproducible HPLC method for simultaneous determination of baicalein and its metabolite baicalin in dog plasma and for the subsequent pharmacokinetic study after iv administration to dogs.Methods An accurate and reproducible HPLC-UV method was developed and validated for simultaneous determination of baicalein and baicalin in dog plasma,using luteolin as internal standard.The analytes were separated by an Agilent Zorbax SB-C18 column(250 mm × 4.6 mm,5 μm) and the column temperature was maintained at 40 ℃.The mobile phase was a binary mixture of acetonitrile and water(27:73) ,containing 0.05% phosphoric acid in water,with a flow rate of 1.0 mL/min.The UV detector was set at 276 nm.Results Linear relationships were validated over the range of 0.05-25 μg/mL for baicalein and 0.05-20 μg/mL for baicalin.The intra-and inter-day precision values for all samples were within 8.0%,using relative standard deviation.This method was successfully applied to the pharmacokinetic studies in dogs after iv administration of baicalein.Baicalein was converted to baicalin quickly.Cmax values were 21.13 μg/mL at 0.05 h for baicalein and 1.57 μg/mL at 0.5 h for baicalin,areas under the plasma concentration-time curve were 4.97 h·μg/mL for baicalein and 0.63 h·μg/mL for baicalin,and the elimination half-life is 0.50 h for baicalein and 0.75 h for baicalin,respectively.Conclusion The method is able and sufficient to be used in drug metabolism and pharmacokinetic studies of baicalein. Objective To develop and validate a simple,rapid,sensitive,and reproducible HPLC method for simultaneous determination of baicalein and its metabolite baicalin in dog plasma and for the subsequent pharmacokinetic study after iv administration to dogs.Methods An accurate and reproducible HPLC-UV method was developed and validated for simultaneous determination of baicalein and baicalin in dog plasma,using luteolin as internal standard.The analytes were separated by an Agilent Zorbax SB-C18 column(250 mm × 4.6 mm,5 μm) and the column temperature was maintained at 40 ℃.The mobile phase was a binary mixture of acetonitrile and water(27:73) ,containing 0.05% phosphoric acid in water,with a flow rate of 1.0 mL/min.The UV detector was set at 276 nm.Results Linear relationships were validated over the range of 0.05-25 μg/mL for baicalein and 0.05-20 μg/mL for baicalin.The intra-and inter-day precision values for all samples were within 8.0%,using relative standard deviation.This method was successfully applied to the pharmacokinetic studies in dogs after iv administration of baicalein.Baicalein was converted to baicalin quickly.Cmax values were 21.13 μg/mL at 0.05 h for baicalein and 1.57 μg/mL at 0.5 h for baicalin,areas under the plasma concentration-time curve were 4.97 h·μg/mL for baicalein and 0.63 h·μg/mL for baicalin,and the elimination half-life is 0.50 h for baicalein and 0.75 h for baicalin,respectively.Conclusion The method is able and sufficient to be used in drug metabolism and pharmacokinetic studies of baicalein.
出处 《Chinese Herbal Medicines》 CAS 2011年第3期196-201,共6页 中草药(英文版)
基金 Research Special Fund for Public Welfare Industry of Health (200902008) Major Scientific and Technological Special Project for "Significant New Drugs Creation" of China (2009ZX09302-003)
关键词 BAICALEIN BAICALIN HPLC PHARMACOKINETICS plasma baicalein baicalin HPLC pharmacokinetics plasma
  • 相关文献

参考文献19

  • 1Cheng Y;He G;Mu X;Zhang T,Li X,Hu J,Xu B,Du G.Neuroprotective effect of baicalein against mptp neurotoxicity:Behavioral,biochemical and immunohistochemical profile[J],2008(01).
  • 2邓远雄,杨昌华,牟玲丽.黄连解毒汤中黄芩苷和汉黄芩苷在糖尿病大鼠体内的药动学[J].中草药,2008,39(2):227-231. 被引量:15
  • 3Gao J;Zhao H;Hylands P J;Corcoran O.Secondary metabolite mapping identifies scutellaria inhibitors of human lung cancer cells,2010(03).
  • 4Gong MT;Yu LF;Chen QH;Xie BY Lu WG.Pharmacokinetic study on baicalin and baicalein after ig administration in rats[J]Chinese Traditional and Herbal Drugs,2009(03).
  • 5Hu JZ;Bai L;Chen DG;Xu QT Southerland WM.Computational investigation of the anti-H1V activity of Chinese medicinal formula three-huang powder,2010(02).
  • 6Jiang M;Porat-Shliom Y;Pei Z;Cheng Y Xiang L Sommers K Li Q Gillardon F Hengerer B Berlinicke C Smith WW Zack DJ Poirier MA Ross CA DuanW.Baicalein reduces e46k alpha-synuclein aggregation in vitro and protects cells against e46k alpha-synuclein toxicity in cell models of familiar parkinsonism[J],2010(02).
  • 7Kotani A;Kojima S;Hakamata H;Kusu F.HPLC with electrochemical detection to examine the pharmacokinetics of baicalin and baicalein in rat plasma after oral administration of a Kampo medicine[J],2006(01).
  • 8Lai MY;Hsiu SL;Tsai SY;Hou YC Chao PD.Comparison of metabolic pharmacokinetics of baicalin and baicalein in rats[J],2003(02).
  • 9Liu CX;Wei GL;Li QS.Methodology study of validation for bioanalysis in studies on pharmacokinetics and bioavailability,2001(04).
  • 10Mu X;He G;Cheng Y;Li X Xu B Du G.Baicalein exerts neuroprotective effects in,6-hydroxydopamine-induced experimental parkinsonism in vivo and in vitro,2009(04).

二级参考文献56

  • 1张文生,朱陵群,邓瑞春,牛福玲,田蓉.红景天甙对缺氧/缺糖损伤的SH-SY5Y细胞线粒体膜电位的影响[J].中国病理生理杂志,2004,20(7):1218-1221. 被引量:17
  • 2Zhu YP. "Chinese Materia Medica." Australia: Harwood academic publfchers; 1998. p127-35.
  • 3Wu S, Sun A, Liu R. Separation and purification of baicalin and wogonoside from the Chinese medicinal plant Scutellaria baicalensis Georgi by high-speed counter-current chromatography. J Chromatogr A 2005; 1066: 243-7.
  • 4thou TC, Chang LP, Li CY, Wong CS, Yang SP. The antiinflammatory and analgesic effects of baicalin in carrageenan-evoked thermal hyperalgesia. Anesth Analq 2003; 17: 1724-9.
  • 5JangSI, Kim H J, Hwang KM, Jekal S J, Pae HO, Choi BM, et al. Hepatoprotective effect of baicalin, a major flavone from Scutellaria radix, on acetaminophen-induced liver injury in mice. Immunopharmacol Immunotoxicol 2003; 25: 585-94.
  • 6Kim DH, Cho KH, Moon SK, Kim YS, Kim DH, Choi JS, et al. Cytoprotective mechanism of baicalin against endothelial cell damage by peroxynitrite. J Pharm Pharmacol 2005; 57: 1581-90.
  • 7AkaoT, Kawabata K, Yanagisawa E, Baicalin, the predominant flavone glucuronide of scutellariae radix, is absorbed from the rat gastrointestinal tract as the aglycone and restored to its original form. J Pharm Pharmacol 2000; 52: 1563-8.
  • 8Yim JS, Kim YS, Moon SK, Cho KH, Bae HS, Kim J J, et al. Metabolic activities of ginsenoside Rbl, baicalin, glycyrrhizin and geniposide to their bioactive compounds by human intestinal microflora. Biol Pharm Bull 2004; 27: 1580-3.
  • 9Abe K, Inoue O, Yumioka E. Biliary excretion of metabolites of baicalin and baica{ein in rats. Chem Pharm Bull 1990; 38: 209-11.
  • 10Akao T, Dakashita Y, Hanada M, Goto H, Shimada Y, Terasawa K. Enteric excretion of baicalein, a flavone of Scutellariae Radix, via glucuronidation in rat: involvement of multidrug resistance-associated protein 2. Pharm Res 2004; 21: 2120-6.

共引文献84

同被引文献61

引证文献5

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部